De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism

Linshan Shang, Lindsay B. Henderson, Megan T. Cho, Donald S. Petrey, Chin To Fong, Katrina M. Haude, Natasha Shur, Julie Lundberg, Natalie Hauser, Jason Carmichael, Jeffrey Innis, Jane Schuette, Yvonne W. Wu, Shailesh Asaikar, Margaret Pearson, Leandra Folk, Kyle Retterer, Kristin G. Monaghan, Wendy K. Chung

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Protein phosphatase 2A (PP2A) is a heterotrimeric protein serine/threonine phosphatase and is involved in a broad range of cellular processes. PPP2R5D is a regulatory B subunit of PP2A and plays an important role in regulating key neuronal and developmental regulation processes such as PI3K/AKT and glycogen synthase kinase 3 beta (GSK3β)-mediated cell growth, chromatin remodeling, and gene transcriptional regulation. Using whole-exome sequencing (WES), we identified four de novo variants in PPP2R5D in a total of seven unrelated individuals with intellectual disability (ID) and other shared clinical characteristics, including autism spectrum disorder, macrocephaly, hypotonia, seizures, and dysmorphic features. Among the four variants, two have been previously reported and two are novel. All four amino acids are highly conserved among the PP2A subunit family, and all change a negatively charged acidic glutamic acid (E) to a positively charged basic lysine (K) and are predicted to disrupt the PP2A subunit binding and impair the dephosphorylation capacity. Our data provides further support for PPP2R5D as a genetic cause of ID.

Original languageEnglish (US)
Pages (from-to)43-49
Number of pages7
JournalNeurogenetics
Volume17
Issue number1
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

Fingerprint

Megalencephaly
Protein Phosphatase 2
Muscle Hypotonia
Autistic Disorder
Intellectual Disability
Exome
Chromatin Assembly and Disassembly
Phosphoprotein Phosphatases
Phosphatidylinositol 3-Kinases
Lysine
Glutamic Acid
Seizures
Amino Acids
Growth
Genes

Keywords

  • Autism spectrum disorder
  • De novo mutations
  • Intellectual disabilities
  • PPP2R5D
  • Protein phosphatase
  • Whole-exome sequencing

Cite this

De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism. / Shang, Linshan; Henderson, Lindsay B.; Cho, Megan T.; Petrey, Donald S.; Fong, Chin To; Haude, Katrina M.; Shur, Natasha; Lundberg, Julie; Hauser, Natalie; Carmichael, Jason; Innis, Jeffrey; Schuette, Jane; Wu, Yvonne W.; Asaikar, Shailesh; Pearson, Margaret; Folk, Leandra; Retterer, Kyle; Monaghan, Kristin G.; Chung, Wendy K.

In: Neurogenetics, Vol. 17, No. 1, 01.01.2016, p. 43-49.

Research output: Contribution to journalArticle

Shang, L, Henderson, LB, Cho, MT, Petrey, DS, Fong, CT, Haude, KM, Shur, N, Lundberg, J, Hauser, N, Carmichael, J, Innis, J, Schuette, J, Wu, YW, Asaikar, S, Pearson, M, Folk, L, Retterer, K, Monaghan, KG & Chung, WK 2016, 'De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism', Neurogenetics, vol. 17, no. 1, pp. 43-49. https://doi.org/10.1007/s10048-015-0466-9
Shang, Linshan ; Henderson, Lindsay B. ; Cho, Megan T. ; Petrey, Donald S. ; Fong, Chin To ; Haude, Katrina M. ; Shur, Natasha ; Lundberg, Julie ; Hauser, Natalie ; Carmichael, Jason ; Innis, Jeffrey ; Schuette, Jane ; Wu, Yvonne W. ; Asaikar, Shailesh ; Pearson, Margaret ; Folk, Leandra ; Retterer, Kyle ; Monaghan, Kristin G. ; Chung, Wendy K. / De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism. In: Neurogenetics. 2016 ; Vol. 17, No. 1. pp. 43-49.
@article{0013e3e2f63d4451bf9e9a7b3cfd503e,
title = "De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism",
abstract = "Protein phosphatase 2A (PP2A) is a heterotrimeric protein serine/threonine phosphatase and is involved in a broad range of cellular processes. PPP2R5D is a regulatory B subunit of PP2A and plays an important role in regulating key neuronal and developmental regulation processes such as PI3K/AKT and glycogen synthase kinase 3 beta (GSK3β)-mediated cell growth, chromatin remodeling, and gene transcriptional regulation. Using whole-exome sequencing (WES), we identified four de novo variants in PPP2R5D in a total of seven unrelated individuals with intellectual disability (ID) and other shared clinical characteristics, including autism spectrum disorder, macrocephaly, hypotonia, seizures, and dysmorphic features. Among the four variants, two have been previously reported and two are novel. All four amino acids are highly conserved among the PP2A subunit family, and all change a negatively charged acidic glutamic acid (E) to a positively charged basic lysine (K) and are predicted to disrupt the PP2A subunit binding and impair the dephosphorylation capacity. Our data provides further support for PPP2R5D as a genetic cause of ID.",
keywords = "Autism spectrum disorder, De novo mutations, Intellectual disabilities, PPP2R5D, Protein phosphatase, Whole-exome sequencing",
author = "Linshan Shang and Henderson, {Lindsay B.} and Cho, {Megan T.} and Petrey, {Donald S.} and Fong, {Chin To} and Haude, {Katrina M.} and Natasha Shur and Julie Lundberg and Natalie Hauser and Jason Carmichael and Jeffrey Innis and Jane Schuette and Wu, {Yvonne W.} and Shailesh Asaikar and Margaret Pearson and Leandra Folk and Kyle Retterer and Monaghan, {Kristin G.} and Chung, {Wendy K.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/s10048-015-0466-9",
language = "English (US)",
volume = "17",
pages = "43--49",
journal = "Neurogenetics",
issn = "1364-6745",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism

AU - Shang, Linshan

AU - Henderson, Lindsay B.

AU - Cho, Megan T.

AU - Petrey, Donald S.

AU - Fong, Chin To

AU - Haude, Katrina M.

AU - Shur, Natasha

AU - Lundberg, Julie

AU - Hauser, Natalie

AU - Carmichael, Jason

AU - Innis, Jeffrey

AU - Schuette, Jane

AU - Wu, Yvonne W.

AU - Asaikar, Shailesh

AU - Pearson, Margaret

AU - Folk, Leandra

AU - Retterer, Kyle

AU - Monaghan, Kristin G.

AU - Chung, Wendy K.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Protein phosphatase 2A (PP2A) is a heterotrimeric protein serine/threonine phosphatase and is involved in a broad range of cellular processes. PPP2R5D is a regulatory B subunit of PP2A and plays an important role in regulating key neuronal and developmental regulation processes such as PI3K/AKT and glycogen synthase kinase 3 beta (GSK3β)-mediated cell growth, chromatin remodeling, and gene transcriptional regulation. Using whole-exome sequencing (WES), we identified four de novo variants in PPP2R5D in a total of seven unrelated individuals with intellectual disability (ID) and other shared clinical characteristics, including autism spectrum disorder, macrocephaly, hypotonia, seizures, and dysmorphic features. Among the four variants, two have been previously reported and two are novel. All four amino acids are highly conserved among the PP2A subunit family, and all change a negatively charged acidic glutamic acid (E) to a positively charged basic lysine (K) and are predicted to disrupt the PP2A subunit binding and impair the dephosphorylation capacity. Our data provides further support for PPP2R5D as a genetic cause of ID.

AB - Protein phosphatase 2A (PP2A) is a heterotrimeric protein serine/threonine phosphatase and is involved in a broad range of cellular processes. PPP2R5D is a regulatory B subunit of PP2A and plays an important role in regulating key neuronal and developmental regulation processes such as PI3K/AKT and glycogen synthase kinase 3 beta (GSK3β)-mediated cell growth, chromatin remodeling, and gene transcriptional regulation. Using whole-exome sequencing (WES), we identified four de novo variants in PPP2R5D in a total of seven unrelated individuals with intellectual disability (ID) and other shared clinical characteristics, including autism spectrum disorder, macrocephaly, hypotonia, seizures, and dysmorphic features. Among the four variants, two have been previously reported and two are novel. All four amino acids are highly conserved among the PP2A subunit family, and all change a negatively charged acidic glutamic acid (E) to a positively charged basic lysine (K) and are predicted to disrupt the PP2A subunit binding and impair the dephosphorylation capacity. Our data provides further support for PPP2R5D as a genetic cause of ID.

KW - Autism spectrum disorder

KW - De novo mutations

KW - Intellectual disabilities

KW - PPP2R5D

KW - Protein phosphatase

KW - Whole-exome sequencing

UR - http://www.scopus.com/inward/record.url?scp=84947434086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947434086&partnerID=8YFLogxK

U2 - 10.1007/s10048-015-0466-9

DO - 10.1007/s10048-015-0466-9

M3 - Article

VL - 17

SP - 43

EP - 49

JO - Neurogenetics

JF - Neurogenetics

SN - 1364-6745

IS - 1

ER -